| ACT | Acceptance and Commitment Therapy |
| AHI | Apnea Hypopnea Index |
| AI | Artificial intelligence |
| Akt | Protein kinase B |
| AMPK | AMP-activated protein kinase |
| apoB | Apolipoprotein B |
| Arc | Arcuate nucleus |
| ATS | Adipocyte-targeting peptide |
| ATS-9R | 9-mer arginine sequence |
| BAT | Brown adipose tissue |
| BBB | Blood–brain barrier |
| BMD | Bone mineral density |
| BMI | Body mass index |
| BPA | Bisphenol A |
| CAAs | Cancer-associated adipocytes |
| cAMP | Cyclic adenosine monophosphate |
| CBT | Cognitive Behavioral Therapy |
| CCK | Cholecystokinin |
| ChREBP | Carbohydrate-responsive element-binding protein |
| CRISPRi | CRISPR interference |
| CVD | Cardiovascular disease |
| DAG | Diacylglycerol |
| dCas9 | Catalytically inactive Cas9 |
| DM | Diabetes mellitus |
| EVs | Extracellular vesicles |
| Fabp4 | Fatty acid-binding protein 4 |
| FOXO1 | Forkhead box 1 |
| FTO | Fat mass and obesity-associated gene |
| GLP-1 | Glucagon-like peptide-1 |
| GLP1RAs | GLP-1 receptor agonists |
| GLUT4 | Glucose transporter type 4 |
| GSK3 | Glycogen synthase kinase-3 |
| HCC | Hepatocellular carcinoma |
| HDL | High-density lipoprotein |
| HDL-C | High-density lipoprotein cholesterol |
| HF | Heart failure |
| HRpEF | Heart failure with preserved ejection fraction |
| IL | Interleukin |
| IR | Insulin resistance |
| IRS-1 | Insulin receptor substrate 1 |
| IRS-2 | Insulin receptor substrate 2 |
| LDL | Low-density lipoprotein |
| LEP | Leptin |
| LEPR | Leptin receptor gene |
| LIR | Liraglutide |
| LLMs | Large language models |
| LV | Left ventricle |
| MASLD | Metabolic Dysfunction-Associated Steatotic Liver Disease |
| MBSR | Mindfulness-Based Stress Reduction |
| MC4R | Melanocortin 4 receptor |
| ML | Machine learning |
| mTORC1 | Mammalian target of rapamycin complex 1 |
| OSA | Obstructive sleep apnea |
| PDE3B | Phosphodiesterase 3B |
| PI3K | Phosphoinositide 3-kinase |
| PKA | Protein kinase A |
| PN | Personalized nutrition |
| PP1 | Protein phosphatase 1 |
| PP2A | Protein phosphatase 2A |
| PPAR-γ | Peroxisome proliferator-activated receptor gamma |
| PPTs | Privacy-preserving technologies |
| PRS | Polygenic risk score |
| PTP1B | Protein tyrosine phosphatase 1B |
| PYY | Peptide YY |
| RAAS | Renin–angiotensin–aldosterone system |
| RYGB | Roux-en-Y gastric bypass |
| SCFAs | Short-chain fatty acids |
| SG | Sleeve gastrectomy |
| SOCS3 | Suppressor of cytokine signaling 3 |
| SREBP-1c | Sterol regulatory element-binding protein 1 |
| TALENs | Transcription activator-like effector nucleases |
| T2DM | Type 2 diabetes mellitus |
| TNF-α | Tumor necrosis factor alpha |
| VAT | Visceral adipose tissue |
| WAT | White adipose tissue |